A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens
Public ClinicalTrials.gov record NCT05370521. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of Tildacerfont in Adult Subjects With Polycystic Ovary Syndrome (PCOS) and Elevated Adrenal Androgens
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
An investigation of the safety and efficacy of tildacerfont in women with PCOS and elevated adrenal androgens
Study identification
- NCT ID
- NCT05370521
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 27 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 15, 2022 (Actual)
- Primary completion
- Aug 3, 2023 (Actual)
- Completion
- Aug 31, 2023 (Actual)
- Last update posted
- Oct 9, 2025
2022 – 2023
United States locations
- U.S. sites
- 21
- U.S. states
- 13
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Spruce Study Site | Sacramento | California | 95817 | — |
| Spruce Study Site | San Francisco | California | 94158 | — |
| Spruce Study Site | New Haven | Connecticut | 06519 | — |
| Spruce Study Site | Clearwater | Florida | 33759 | — |
| Spruce Study Site | Lake Worth | Florida | 33461 | — |
| Spruce Study Site | Miami | Florida | 33173 | — |
| Spruce Study Site | Winter Park | Florida | 32792 | — |
| Spruce Study Site | Idaho Falls | Idaho | 83404 | — |
| Spruce Study Site | Wichita | Kansas | 67226 | — |
| Spruce Study Site | Boston | Massachusetts | 02115 | — |
| Spruce Study Site | Fall River | Massachusetts | 02720 | — |
| Spruce Study Site | Southfield | Michigan | 48034 | — |
| Spruce Study Site | Williamsville | New York | 14221 | — |
| Spruce Study Site | Raleigh | North Carolina | 27612 | — |
| Spruce Study Site | Cincinnati | Ohio | 45219 | — |
| Spruce Study Site | Cleveland | Ohio | 44106 | — |
| Spruce Study Site | Philadelphia | Pennsylvania | 19104 | — |
| Spruce Study Site | Bedford | Texas | 76022 | — |
| Spruce Study Site | Houston | Texas | 77024 | — |
| Spruce Study Site | Houston | Texas | 77030 | — |
| Spruce Study Site | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05370521, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05370521 live on ClinicalTrials.gov.